GANNON STEVEN 4
4 · Xenon Pharmaceuticals Inc. · Filed Jun 29, 2022
Insider Transaction Report
Form 4
GANNON STEVEN
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-28+18,000→ 18,000 totalExercise: $30.11Exp: 2032-06-27→ Common Shares (18,000 underlying)
Footnotes (1)
- [F1]100% of the common shares subject to the option will vest on the earlier of (i) the first anniversary of grant date and (ii) the day immediately preceding the day of the Issuer's next annual general meeting of shareholders.